Show simple item record

dc.contributor.authorAr, Muhlis Cem
dc.contributor.authorFirtina, Sinem
dc.contributor.authorElverdi, Tuğrul
dc.contributor.authorErbilgin, Yücel
dc.contributor.authorEskazan, AHMET EMRE
dc.contributor.authorNG, Ozden Hatirnaz
dc.contributor.authorTATONYAN, Suzin Catal
dc.contributor.authorAYDIN, Seniz Ongoren
dc.contributor.authorFERHANOGLU, A. Burhan
dc.contributor.authorAydin, Yıldız
dc.contributor.authorSoysal, Teoman
dc.contributor.authorOzbek, UĞUR
dc.contributor.authorBaslar, Zafer
dc.contributor.authorSayitoglu, Müge
dc.contributor.authorSalihoglu, Ayşe
dc.date.accessioned2021-03-05T07:48:21Z
dc.date.available2021-03-05T07:48:21Z
dc.identifier.citationErbilgin Y., Eskazan A. E. , NG O. H. , Salihoglu A., Elverdi T., Firtina S., TATONYAN S. C. , AYDIN S. O. , Ar M. C. , Baslar Z., et al., "Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance", 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, Amerika Birleşik Devletleri, 7 - 10 Aralık 2013, cilt.122
dc.identifier.othervv_1032021
dc.identifier.otherav_95a615d7-c74d-4e9b-815e-56546fe9014a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/100764
dc.identifier.urihttps://doi.org/10.1182/blood.v122.21.384.384
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleNext-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume122
dc.contributor.firstauthorID66456


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record